Giovanni Brandi

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen et al. · The Lancet Oncology · 2019 · 1.7K citations

Medicine, Oncology, Pharmacology +13

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

Valérie Gaboriau‐Routhiau, Sabine Rakotobé, Emelyne Lécuyer et al. · Immunity · 2009 · 1.4K citations · Full text

Life Sciences, Immunology, Microbiology +17

Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

Stefano Bellentani, Gioconda Saccoccio, Flora Masutti et al. · Annals of Internal Medicine · 2000 · 1.3K citations

Medicine, Public Health Nutrition, Hepatology +11

ecancermedicalscience

Gauthier Bouche, Nicolás André, Shripad Banavali et al. · ecancermedicalscience · 2016 · 679 citations · Full text

Pharmacy, Oncology, Oncology Nursing +13

Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?

Matteo Renzulli, Stefano Brocchi, Alessandro Cucchetti et al. · Radiology · 2015 · 370 citations · Full text

Medicine, Oncology, Radiology +17